Surmodics Inc reports results for the quarter ended June 30 - Earnings Summary

• Surmodics Inc SRDX.OQ reported quarterly adjusted earnings of 6 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -27 cents. The mean expectation of two analysts for the quarter was for a loss of 19 cents per share. Wall Street expected results to range from -21 cents to -16 cents per share.

• Revenue fell 2.6% to $29.57 million from a year ago; analysts expected $28.06 million.

• Surmodics Inc's reported EPS for the quarter was a loss of 37 cents​.

• The company reported a quarterly loss of $5.32 million.

• Surmodics Inc shares had risen by 17.8% this quarter and lost 11.6% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 3.9% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

This summary was machine generated from LSEG data August 8 at 02:11 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)